- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00560105
Randomized Controlled Eight-Week Study of the Safety and Efficacy of the Lung Flute
March 4, 2015 updated by: Medical Acoustics LLC
A Proof of Principal Randomized Controlled Eight-Week Study of the Safety and Efficacy of the Lung Flute in Adults With Chronic Obstructive Pulmonary Disease. A FDA 510(k) Equivalency Study
This is an eight-week, randomized, controlled, two arm parallel study.
The study consists of, a screening visit, two weeks of intervention-free run-in randomization, clinic visits week 0, 1, 2, 4, 6, and 8 weeks during the intervention period to collect 24 hour sputum and to confirm techniques of device use and entries into daily diaries.
Twenty-four (24) hour sputum samples will be collected and weighed at each clinic visit.
In addition to clinic visits, subjects will be expected to make daily diary entries of COPD symptoms.
Clinical evaluation will include adverse event surveillance, and St. Georges Respiratory questionnaire.
Study Overview
Detailed Description
No further details
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14215
- VA Western NY Healthcare System
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age of over 40 with COPD
Exclusion Criteria:
- Children,
- New mothers; and
- Women intending to become pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Acapella
The Active Comparator is the Acapella, a OPEP device
|
8 weeks home use, twice daily
|
Experimental: Lung Flute
The Active Comparator is the Lung Flute, a new indication of this device
|
8 weeks home use, twice daily
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety and Efficacy of the Lung Flute Versus the Acapella for the Treatment of COPD in Adults. Twenty-four (24) Hour Dry Sputum Weight
Time Frame: 8 weeks
|
In order to test the overall treatment effect on dry sputum weight over the course of the study, mixed effects analysis were performed.
These models allow us to account for the longitudinal nature of the data.
We assumed that the observations collected within each patient were correlated; however, observations collected across patients were assumed to be independent.
Dry sputum weights obtained prior to and at randomization were regarded as baseline measurements, while those obtained at week 1, 2, 4, 6 and 8 were examined for treatment effects.
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
FEV1 - Baseline and Device Comparisons
Time Frame: 8 weeks
|
Spirometric data was collected primarily to document safety of the interventions.
Pre- and Post-bronchodilator spirometry was obtained at the randomization visit and at Week 8.
|
8 weeks
|
Quality of Life Questionnaire/Daily Diary
Time Frame: 8 weeks
|
St. George's Respiratory Questionnaire (SGRQ) is a well validated, widely used health status questionnaire specific for COPD.
Its minimum important difference (MID) is 4 units.
Unit of measure: 0 to 100 (100 = more limitation)
|
8 weeks
|
Change in CCQ Score
Time Frame: 8 weeks
|
The COPD Clinical Questionnaire (CCQ) is an objective validated tool to assess COPD symptoms.
CCQ was measured at the randomization visit and at the end of the study visit at week 8.
The CCQ is scaled 1 to 5. Five indicating no symptoms.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sanjay Sethi, MD, VA Western NY Healthcare System
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2007
Primary Completion (Actual)
December 1, 2008
Study Completion (Actual)
December 1, 2008
Study Registration Dates
First Submitted
November 15, 2007
First Submitted That Met QC Criteria
November 16, 2007
First Posted (Estimate)
November 19, 2007
Study Record Updates
Last Update Posted (Estimate)
March 5, 2015
Last Update Submitted That Met QC Criteria
March 4, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 1002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COPD
-
University Medical Center GroningenCompleted
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
University Hospital, BrestRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Baylor Research InstituteNot yet recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
Clinical Trials on Acapella
-
NHS LothianCompletedIs Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?BronchiectasisUnited Kingdom
-
Seoul National University HospitalCompletedPulmonary Resection SurgeryKorea, Republic of
-
Cairo UniversityRecruitingHeart Diseases | Heart Valve Diseases | Open Heart SurgeryEgypt
-
New York Presbyterian Brooklyn Methodist HospitalCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
PSG College of PhysiotherapyUnknownChronic Obstructive Pulmonary DiseaseIndia
-
Universidad San JorgeCompleted
-
South Valley UniversityRecruiting
-
Riphah International UniversityCompletedChronic Obstructive Pulmonary DiseasePakistan
-
South Valley UniversityActive, not recruitingCoronary Artery Bypass Graft SurgeryEgypt